Is Aniridia hereditary?

Aniridia is primarily a genetic condition caused by mutations in the PAX6 gene, and while it is often hereditary, it can also occur as a spontaneous, non-inherited event.

In clinical genetics, we distinguish between a condition being "genetic" (caused by a change in DNA) and "hereditary" (passed from parent to child). Aniridia is both, but the way it presents in families varies significantly. In approximately two-thirds of cases, the condition is inherited in an autosomal dominant pattern, meaning an affected parent has a 50% chance of passing the PAX6 mutation to each child. However, about one-third of Aniridia cases are the result of a de novo mutation, meaning the genetic change occurred spontaneously in the individual, even if neither parent carries the mutation.

Genetic Testing and Counseling

Genetic testing is highly recommended to confirm an Aniridia diagnosis and identify the specific mutation involved. Testing is typically performed via blood samples to analyze the PAX6 gene or, in some instances, adjacent genes if WAGR syndrome (Wilms tumor, Aniridia, Genitourinary anomalies, and Range of developmental delays) is suspected. Because the clinical presentation of Aniridia can vary even within the same family, genetic counseling is essential for families planning a pregnancy. Counselors help parents understand the recurrence risk and discuss reproductive options, such as preimplantation genetic testing (PGT) for those who wish to screen embryos.

Understanding Inheritance

Because Aniridia is typically autosomal dominant, it does not skip generations in the classic sense; if an individual has the mutation, they are generally expected to manifest symptoms, though the severity of ocular issues can differ. While carrier testing is not standard for the general population, it is vital for siblings and extended family members of an affected individual to undergo clinical eye examinations and genetic counseling to determine their own risk status. Understanding the genetic basis of Aniridia empowers families to make informed healthcare decisions and ensures early screening for associated systemic conditions.

Disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult with your ophthalmologist or a board-certified genetic counselor regarding your specific medical situation.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Aniridia


• Orphanet: Congenital Aniridia


• OMIM (Online Mendelian Inheritance in Man): Aniridia Type 1


• The Aniridia Foundation International